Sudarshan Jain, Author at Express Pharma - Page 164 of 1178

Sudarshan Jain highlights Indian pharma’s path to $130 billion by 2030

Rethinking R&D to balance efficiency, innovation and sustainability

Lupin secures FDA approval for generic Emtricitabine and Tenofovir Alafenamide tablets

Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData

Cipla launches CipAir App for asthma screening in India

12-month diagnosed prevalent cases of severe asthma across 8MM to reach 1.89 million in 2033, forecasts GlobalData

B&R drives adaptive manufacturing solutions in pharma production

SPARC partners with UCSF and Tiller Therapeutics to license oncology asset

Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025

Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets